Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03BHM
|
|||
| Former ID |
DCL000603
|
|||
| Drug Name |
R1507
|
|||
| Indication | Graves ophthalmopathy [ICD-11: 9C82.3; ICD-10: H49-H52] | Phase 2 | [1] | |
| Company |
Roche
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H12N2O2
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C=CC(=N2)C=CC3=CC(=CC=C3)[N+](=O)[O-]
|
|||
| InChI |
1S/C17H12N2O2/c20-19(21)16-6-3-4-13(12-16)8-10-15-11-9-14-5-1-2-7-17(14)18-15/h1-12H/b10-8+
|
|||
| InChIKey |
URIXDBULDXTIHZ-CSKARUKUSA-N
|
|||
| CAS Number |
CAS 7251-91-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015801) | |||
| REF 2 | Clinical pipeline report, company report or official report of Roche (2009). | |||
| REF 3 | National Cancer Institute. Dictionary of Cancer Terms. 2009. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.